Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | PNP | P00491 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26233540 | 1.00 | HIF1A (0.60) | HIF1APNPLMNATP53HTT | |
| SCHEMBL9142309 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL21563936 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL30818467 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL5982644 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL5982637 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL18486197 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL21563846 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL18862687 | 0.89 | HIF1A (0.71) | HIF1APNPLMNATP53HTT | |
| SCHEMBL14639883 | 0.86 | POLB (0.62) | HIF1APNPLMNATP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230264164-A1 | HOMOPOLYMER ENCODED NUCLEIC ACID MEMORY | TRILINK BIOTECHNOLOGIES, LLC | 2023-08-24 | — | — | US | disclosed |
| US-20230264164-A1 | HOMOPOLYMER ENCODED NUCLEIC ACID MEMORY | TRILINK BIOTECHNOLOGIES, LLC | 2023-08-24 | — | — | US | disclosed |
| US-8680062-B2 | System for delivering therapeutic agents into living cells and cells nuclei | Deliversir Ltd. (IL) | 2014-03-25 | — | — | US | disclosed |
| US-20080004234-A1 | System for delivering therapeutic agents into living cells and cells nuclei | SEGEV LABORATORIES LIMITED (IL) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004234-A1 | System for delivering therapeutic agents into living cells and cells nuclei | RCC1, NUMA1, ACIN1 | HIF1A 3864/4885PNP 2386/4885LMNA 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.